Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05248672 · ClinicalTrials.gov registry record · Phase 1
Study to Assess the Pharmacokinetics of CT1812 in Older Healthy Volunteers
A Phase 1 study, sponsored by Cognition Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
NCT05248672 is a Phase 1 study that has completed, run by Cognition Therapeutics. The registered enrollment target is 35 participants.
The verdict
NCT05248672, a Phase 1 study, has completed, sponsored by Cognition Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
Study Summary
This an open label study to assess the pharmacokinetics of CT1812 in normal healthy volunteers.
Interventions
- DRUG CT1812
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2022-02-15 |
| Est. Completion | 2022-06-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05248672
The ClinicalTrials.gov registry entry for NCT05248672 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cognition Therapeutics, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CT1812 is the first listed.
NCT05248672 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05248672 about?
NCT05248672 is a clinical study titled "Study to Assess the Pharmacokinetics of CT1812 in Older Healthy Volunteers". This an open label study to assess the pharmacokinetics of CT1812 in normal healthy volunteers.
What is the current status of trial NCT05248672?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2022-02-15. Estimated completion is 2022-06-01.
What interventions are being tested in trial NCT05248672?
The interventions under investigation include: CT1812 (DRUG).
Who is sponsoring clinical trial NCT05248672?
This trial is sponsored by Cognition Therapeutics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.